Showing results (81-90 of 95) with videos related to
Sort By:
Pageof 10
Zhonghua Yi Xue Za Zhi|June 27, 2017
[Circulating tumor cells in patients with breast tumors were detected by a novel device: a multicenter, clinical trial in China]J B Li, C Z Geng, M Yan, et al.Proceedings of the National Academy of Sciences of the United States of America|June 1, 1987
Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptideK B Cease, H Margalit, J L Cornette, et al.Journal of Animal Science|February 5, 2008
Trichostatin A and nuclear reprogramming of cloned rabbit embryosL H Shi, J S Ai, Y C Ouyang, et al.Bulletin of the World Health Organization|January 1, 1988
Effectiveness of amodiaquine, sulfadoxine-pyrimethamine, and combinations of these drugs for treating chloroquine-resistant falciparum malaria in Hainan Island, ChinaO L Huang, W C Ouyang, J X Zhou, et al.Zhonghua Yi Xue Za Zhi|May 11, 2018
[Study of bioequiavailability of paclitaxel for Injection (Albumin Bound) and abraxane and the efficacy of extension treatments in patients with metastatic breast cancer]L Bian, C Z Geng, Q C Ouyang, et al.Gynecologic Oncology|June 1, 1984
Secretion of human chorionic gonadotropin and alpha-fetoprotein by an ovarian germ cell tumor of apparent yolk sac originS C Huang, H C Chen, R J Kurman, et al.Cell Death & Disease|March 29, 2014
Survivin is essential for fertile egg production and female fertility in miceZ-Z Jiang, M-W Hu, Z-B Wang, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|March 18, 2024
[Gemcitabine long-term maintenance chemotherapy benefits patients with survival: a multicenter, real-world study of advanced breast cancer treatment in China]J Yue, G H Song, H P Li, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 28, 2023
[A real-world study on the efficacy and safety analysis of paclitaxel liposome in advanced breast cancer]C X Sun, S S Wang, J B Li, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2019
Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancerA B Schrock, C Ouyang, J Sandhu, et al.Pageof 10